Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | LGND | ACAD | ||
| Company | Apellis Pharmaceuticals Inc | Ligand Pharm | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.05 | 291.02 | 30.66 | ||
| High | 41.07 | 294.61 | 30.96 | ||
| Low | 41.03 | 282.25 | 30.07 | ||
| Last | 41.03 | 290.71 | 30.21 | ||
| Change | -0.03 | +3.12 | +0.03 | ||
| Percent Change | -0.07% | +1.08% | +0.10% | ||
| Volume | 68,611,400 | 231,100 | 2,288,000 | ||
| 20-Day Average Volume | 7,541,190 | 285,940 | 1,796,570 | ||
| Previous | 41.06 | 287.59 | 30.18 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.97 | 294.41 | 27.67 | ||
| 20-Day Raw Stochastic | 67.65% | 24.01% | 88.85% | ||
| 20-Day Relative Strength | 81.66 | 50.53 | 69.46 | ||
| Weighted Alpha | +25.64 | +83.59 | +31.62 | ||
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 05/06/26 | -0.87% since 08/12/26 | +2.58% since 08/12/26 | ||
| Low | 40.98 on 05/07/26 | 282.25 on 08/19/26 | 27.90 on 08/14/26 | ||
| High | 41.08 on 05/12/26 | 298.29 on 08/17/26 | 30.96 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +0.47% since 04/13/26 | -4.18% since 07/17/26 | +18.01% since 07/17/26 | ||
| Low | 40.78 on 04/14/26 | 282.25 on 08/19/26 | 24.23 on 07/23/26 | ||
| High | 41.14 on 05/06/26 | 317.49 on 08/06/26 | 30.96 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +89.08% since 02/13/26 | +39.91% since 05/19/26 | +47.51% since 05/19/26 | ||
| Low | 16.83 on 03/30/26 | 209.38 on 05/20/26 | 20.41 on 05/21/26 | ||
| High | 41.14 on 05/06/26 | 326.63 on 07/08/26 | 30.96 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +107.12% since 11/13/25 | +56.03% since 02/19/26 | +24.17% since 02/19/26 | ||
| Low | 16.83 on 03/30/26 | 178.72 on 02/26/26 | 19.89 on 03/19/26 | ||
| High | 41.14 on 05/06/26 | 326.63 on 07/08/26 | 30.96 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,252,701 | 5,733,395 | 5,200,195 | ||
| Shares Outstanding, K | 128,021 | 19,936 | 172,306 | ||
| Annual Sales, $M | 1,003,780,000 | 268,090,000 | 1,071,510,000 | ||
| Annual Net Income, $M | 22,390,000 | 124,450,000 | 391,000,000 | ||
| Last Qtr Sales, $M | 268,300,000 | 63,690,000 | 307,960,000 | ||
| Last Qtr Income, $M | 18,660,000 | 48,510,000 | 31,500,000 | ||
| 60-Month Beta | -0.24 | 1.13 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/07/26 | 2.37 on 08/06/26 | 0.18 on 08/04/26 | ||
| Latest Earnings Date | 07/30/26 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | 2.500 on 04/03/07 | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.25 | 31.21 | 46.79 | ||